Guardant Health (US.GH)
Capital Allocation Audit · Period: 2016 – 2026
Key Metrics
US.GH · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 114.1% | ↑ |
| ROE | - | → |
| Cash Conversion | - | → |
| D/E Ratio | - | → |
| Gross Margin | 65.3% | → |
US.GH (Guardant Health) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 114.1% ↑ ROE - → Cash Conversion - → D/E Ratio - → Gross Margin 65.3% →
Key Metrics
US.GH (Guardant Health) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 114.1% ↑ROE - →Cash Conversion - →D/E Ratio - →Gross Margin 65.3% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies